Cellebrite DI Ltd.
CLBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3,846 | $4,830 | $5,138 |
| - Cash | $281 | $179 | $90 | $192 |
| + Debt | $18 | $22 | $11 | $11 |
| Enterprise Value | – | $3,689 | $4,750 | $4,958 |
| Revenue | $126 | $113 | $108 | $109 |
| % Growth | 11.3% | 5.3% | -1.4% | – |
| Gross Profit | $106 | $96 | $90 | $91 |
| % Margin | 83.9% | 84.4% | 83.7% | 83.8% |
| EBITDA | $27 | $17 | $15 | $18 |
| % Margin | 21.4% | 15% | 13.9% | 16.9% |
| Net Income | $20 | $19 | $17 | $19 |
| % Margin | 16% | 17.2% | 16.2% | 17.7% |
| EPS Diluted | 0.08 | 0.078 | 0.07 | 0.078 |
| % Growth | 2.3% | 11.7% | -10.1% | – |
| Operating Cash Flow | $33 | $33 | $21 | $66 |
| Capital Expenditures | -$3 | -$4 | -$2 | -$4 |
| Free Cash Flow | $30 | $29 | $19 | $62 |